Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90
Allogeneic natural killer (aNK) cell adoptive therapy has the potential to dramatically impact clinical outcomes of glioblastoma multiforme (GBM). However, in order to exert therapeutic activity, NK cells require tumor expression of ligands for activating receptors, such as MHC Class I peptide A/B (...
Saved in:
Main Authors: | Tanmoy Saha, Amanda A. van Vliet, Chunxiao Cui, Jorge Jimenez Macias, Arpita Kulkarni, Luu Nhat Pham, Sean Lawler, Jan Spanholtz, Anna-Maria Georgoudaki, Adil Doganay Duru, Aaron Goldman |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e47ed6b00c7f48eaa54b2fa0f80f11a6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Tumor Activity of Expanded PBMC-Derived NK Cells by Feeder-Free Protocol in Ovarian Cancer
by: Minhua Chen, et al.
Published: (2021) -
Neoplasia blástica de células dendríticas plasmocitoides. Casos clínicos
by: Avilés-Salas,Alejandro, et al.
Published: (2017) -
Leucemia de células natural killer: Caso clínico
by: Guerrero A,Mario, et al.
Published: (2005) -
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
by: Erica L. Heipertz, et al.
Published: (2021) -
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
by: Yan-Ruide Li, et al.
Published: (2021)